SSR128129E
SSR128129E is an orally bioavailable, allosteric inhibitor that selectively targets FGFR1 with an IC50 of 1.9 μM. Its specificity makes it a valuable research tool for investigating FGFR1 signaling in cancer models, with applications in both in vitro biochemical assays and in vivo xenograft studies.
Product Specifications
CAS Number
848318-25-2
Product Name Alternative
SSR, SSR 128129E, SSR128129E, SSR-128129E, FGFR, FGFR1
Field of Research
Cardiovascular Research, Signal Transduction
Purity
≥95% (May vary between batches)
Solubility
H2O:1 mg/mL (2.89 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.78 mM) ; DMSO:45 mg/mL (129.94 mM)
Smiles
[Na+].COc1c (C) c (C (=O) c2ccc (N) c (c2) C ([O-]) =O) n2ccccc12
Molecular Formula
C18H15N2O4·Na
Molecular Weight
346.31
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL500724V 500 µL Each
Fn1 Mouse shRNA Lentiviral Particle (Locus ID 14268)
Sign In for Pricing
View Details 
GTR15120240 1 Vial
Lentiviral human CHKA shRNA (UAS) - Lentiviral human CHKA shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details